ARGONAUT THERAPEUTICS LIMITED
OXFORD

Hellopages » Oxfordshire » Oxford » OX4 4GA

Company number 09993166
Status Active
Incorporation Date 8 February 2016
Company Type Private Limited Company
Address MAGDALEN CENTRE ROBERT ROBINSON AVENUE, OXFORD SCIENCE PARK, OXFORD, UNITED KINGDOM, OX4 4GA
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration nine events have happened. The last three records are Confirmation statement made on 7 February 2017 with updates; Appointment of Dr. Andrew Mclean as a director on 14 April 2016; Statement of capital following an allotment of shares on 14 April 2016 GBP 1,666.70 . The most likely internet sites of ARGONAUT THERAPEUTICS LIMITED are www.argonauttherapeutics.co.uk, and www.argonaut-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is nine years and ten months. Argonaut Therapeutics Limited is a Private Limited Company. The company registration number is 09993166. Argonaut Therapeutics Limited has been working since 08 February 2016. The present status of the company is Active. The registered address of Argonaut Therapeutics Limited is Magdalen Centre Robert Robinson Avenue Oxford Science Park Oxford United Kingdom Ox4 4ga. . MCDONALD, Douglas is a Secretary of the company. LA THANGUE, Nicholas Barrie, Prof is a Director of the company. MCLEAN, Andrew, Dr is a Director of the company. The company operates in "Research and experimental development on biotechnology".


Current Directors

Secretary
MCDONALD, Douglas
Appointed Date: 13 April 2016
Director
LA THANGUE, Nicholas Barrie, Prof
Appointed Date: 08 February 2016
68 years old
Director
MCLEAN, Andrew, Dr
Appointed Date: 14 April 2016
40 years old

Persons With Significant Control

Prof Nicholas Barrie La Thangue
Notified on: 6 April 2016
68 years old
Nature of control: Ownership of shares – 75% or more
Oxford Sciences Innovation Plc
Notified on: 6 April 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%

ARGONAUT THERAPEUTICS LIMITED Events

20 Feb 2017
Confirmation statement made on 7 February 2017 with updates
26 Apr 2016
Appointment of Dr. Andrew Mclean as a director on 14 April 2016
26 Apr 2016
Statement of capital following an allotment of shares on 14 April 2016
  • GBP 1,666.70
26 Apr 2016
Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES11 ‐ Resolution of removal of pre-emption rights
26 Apr 2016
Appointment of Douglas Mcdonald as a secretary on 13 April 2016
26 Apr 2016
Statement of capital following an allotment of shares on 13 April 2016
  • GBP 1,000
26 Apr 2016
Sub-division of shares on 13 April 2016
26 Apr 2016
Resolutions
  • RES13 ‐ Subdivision 13/04/2016
  • RES11 ‐ Resolution of removal of pre-emption rights
08 Feb 2016
Incorporation
Statement of capital on 2016-02-08
  • GBP 100
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Similar Companies

ARGONAUT TAX CONSULTANCY LIMITED ARGONAUT TECHNOLOGIES LTD ARGONAUT TOPCO LIMITED ARGONAUT TRADING LTD ARGONAUT TRAINING FACILITIES LIMITED ARGONAUTA LTD ARGONAUTAE LIMITED